Thermo Fisher Scientific (TMO): Carnegie Investment Counsel reduced its stake -5,590 shares
Carnegie Investment Counsel reduced its stake in Thermo Fisher Scientific, per its Q1 2026 13F.
- 42K
- Shares reported · -5,590 vs prior quarter
- 0.40%
- Disclosed portfolio weight
- $20.6M
- Reported value
- Holdings as of
- Mar 31, 2026
- Filed
- May 1, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 12, 2024CongressDisclosed sale of TMO — reported range $1,001 - $15,000
- Mar 3, 2026Insider · 1 personInsiders: 12 sales (~$2.5M)
- Mar 4, 2026Insider · 1 personInsiders: 8 sales (~$2.6M)
- Mar 5, 2026Insider · 1 personInsiders: 13 sales (~$2.1M)
- Mar 11, 2026InsiderOfficer sold ~$803K of TMO shares in the open market
- Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 27, 2026Federal contract · $4.5M obligatedDepartment of Commerce awarded Thermo Fisher Scientific: $4.49M obligated to date
- Mar 27, 2026CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
- Apr 23, 2026Company filing · Form 8-K · ResultsReported its results
- Apr 27, 2026InsiderOfficer sold ~$185K of TMO shares in the open market
- Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
What came next
- May 7, 2026CongressDisclosed partial sale of TMO — reported range $1,001 - $15,000
- Jun 4, 2026Federal contract · $1.6M obligatedDepartment of Defense awarded Thermo Fisher Scientific: $1.57M obligated to date
- Jun 9, 2026Federal contract · $1.5M obligatedDepartment of Agriculture awarded Thermo Fisher Scientific: $1.5M obligated to date
- Jul 10, 2026CongressDisclosed sale of TMO — reported range $1,001 - $15,000
- Jul 21, 2026Government · Federal Register noticeGranting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules
- Jul 23, 2026Company filing · Form 8-K · ResultsReported its results
- Jul 24, 2026FDAFDA device clearance: Thermo Scientific Oxoid Cefepime/Zidebactam Disc (30/30 µg) FPZ60
- Jul 27, 2026InsiderOfficer sold ~$226K of TMO shares in the open market
- Aug 5, 2026Insider · 1 personInsiders: 18 sales (~$6.4M)
- Aug 6, 2026Insider · 2 peopleInsiders: 19 sales (~$12.0M)
- Aug 14, 2026FDARecall: Ion Torrent Genexus Dx with software, Catalog: A40003539, which supports the Ion Torrent Genexus Dx Integrated Sequencer
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Thermo Fisher Scientific
For Thermo Fisher Scientific, OQRO holds 26 insider filings (SEC Form 4 or Form 144), 6 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TMO page.
How this filing works
Explore the data
Common questions
What does this filing report about Thermo Fisher Scientific (TMO) stock?
Carnegie Investment Counsel reduced its stake in Thermo Fisher Scientific, per its Q1 2026 13F. Now 42K shares, $20.6M reported value, 0.40% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Mar 31, 2026. Filed: May 1, 2026.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Thermo Fisher Scientific recently?
For Thermo Fisher Scientific, OQRO holds 26 insider filings (SEC Form 4 or Form 144), 6 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the TMO page.
Does this mean TMO stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Thermo Fisher Scientific
- SEC Form 13F-HRNov 16, 2026
- SEC Form 4Nov 16, 2026
- SEC Form 4Nov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
Everything OQRO holds on this company is on its TMO page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
